Open access · OA
via Europe PMC
Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential.
Gadhave DG, Jadhav AB, Waghamode NB, Khot S, Khan R, Hole R, Dhobale SM, Aswar M, Paudel KR.
Advanced healthcare materials · 2026
Abstract
Aging is a significant risk factor of neurodegenerative disorders (NDs) such as Huntington's, Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). Although several clinical, neuroimaging, and biomarker-based diagnostic approaches are available for NDs, their limited sensitivity for early-stage detection, disease specificity, and prediction of disease progression continue to present significant clinical challenges, often resulting in delayed diagnosis and therapeutic intervention. According to previously published works, the preliminary pathological feature of such disorders is mitochondrial dysfunction(definition). This may lead to elevated oxidative stress, impaired mitophagy, unbalanced mitochondrial function, and bioenergetic failure. This review examines how mitochondria-targeted nanotherapeutic approaches can overcome these pathological barriers and improve therapeutic outcomes in aging-associated neurodegeneration. Targeted delivery of drug-loaded nanocarriers, such as gene-delivery, lipid-based, metallic, and polymeric nanoparticles, has emerged as a potential platform to deliver medication directly to defective mitochondria. It may increase mitochondrial biogenesis, maintain redox balance, and protect against neuronal degeneration. This work incorporates disease-specific mitochondrial pathology with current progress in targeted nanotherapeutics, age-associated delivery barriers, clinical revolution, and emerging artificial intelligence (AI)-enabled precision therapeutic approaches. Mitochondria-targeted nanotherapeutics depict a potential disease-modifying strategy for aging-related NDs. However, further advancements in targeting efficacy, scalable production, long-term safety, and clinical validation can facilitate a successful clinical revolution.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/adhm.71594
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
DG, G., AB, J., NB, W., S, K., R, K., R, H., SM, D., M, A., & KR., P. (2026). Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential. <em>Advanced healthcare materials</em>. https://doi.org/10.1002/adhm.71594
Vancouver
DG G, AB J, NB W, S K, R K, R H, et al. Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential. Advanced healthcare materials. 2026. doi:10.1002/adhm.71594.
BibTeX
@article{gadhave2026Mitoch,
title = {Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential.},
author = {Gadhave DG and Jadhav AB and Waghamode NB and Khot S and Khan R and Hole R and Dhobale SM and Aswar M and Paudel KR.},
journal = {Advanced healthcare materials},
year = {2026},
doi = {10.1002/adhm.71594},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Adolescencia e Saude 2026
Open access · CC-BY
Mitophagy Dysfunction in Neurodegenerative Diseases: Molecular Mechanisms, Disease-Specific Pathways and Therapeutic Targets
Frontiers in Neuroscience 2017
Open access · CC-BY
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Journal of Translational Medicine 2025
Open access · CC-BY
Exosomes in aging and age-related disorders: mechanisms, therapeutic potentials, and challenges
Frontiers in pharmacology 2026
Open access · OA
Natural polysaccharides as modulators of mitochondrial homeostasis: structural determinants, pharmacological mechanisms, and translational challenges.
MedComm – Future Medicine 2025
Open access · CC-BY
Mitochondrial Dysfunction in Aging: Future Therapies and Precision Medicine Approaches
Pharmacological research 2026
Citation only